183 related articles for article (PubMed ID: 36973439)
1. Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway.
Park WY; Gray JM; Holewinski RJ; Andresson T; So JY; Carmona-Rivera C; Hollander MC; Yang HH; Lee M; Kaplan MJ; Cappell SD; Yang L
Nat Cancer; 2023 Mar; 4(3):419-435. PubMed ID: 36973439
[TBL] [Abstract][Full Text] [Related]
2. S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.
Hou S; Tian T; Qi D; Sun K; Yuan Q; Wang Z; Qin Z; Wu Z; Chen Z; Zhang J
Cell Death Dis; 2018 Feb; 9(3):277. PubMed ID: 29449540
[TBL] [Abstract][Full Text] [Related]
3. S100A4 is secreted by airway smooth muscle tissues and activates inflammatory signaling pathways via receptors for advanced glycation end products.
Wu Y; Zhang W; Gunst SJ
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L185-L195. PubMed ID: 32432920
[TBL] [Abstract][Full Text] [Related]
4. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
5. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
6. The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells.
Wuren T; Huecksteadt T; Beck E; Warren K; Hoidal J; Ostrand-Rosenberg S; Sanders K
Cell Immunol; 2021 Jul; 365():104379. PubMed ID: 34038758
[TBL] [Abstract][Full Text] [Related]
7. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
[TBL] [Abstract][Full Text] [Related]
8. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
9. Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis.
Ryan D; Koziol J; ElShamy WM
Sci Rep; 2019 Dec; 9(1):19150. PubMed ID: 31844158
[TBL] [Abstract][Full Text] [Related]
10. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages.
Haase-Kohn C; Wolf S; Herwig N; Mosch B; Pietzsch J
Biochem Biophys Res Commun; 2014 Mar; 446(1):143-8. PubMed ID: 24613382
[TBL] [Abstract][Full Text] [Related]
11. S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain.
Khan MI; Yuan T; Chou RH; Yu C
PLoS One; 2019; 14(2):e0212299. PubMed ID: 30779808
[TBL] [Abstract][Full Text] [Related]
12. Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR-ERK-S100A4 signaling.
Liu A; Li Y; Lu S; Cai C; Zou F; Meng X
Cell Death Dis; 2023 Jul; 14(7):395. PubMed ID: 37400459
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?
Wolf S; Haase-Kohn C; Lenk J; Hoppmann S; Bergmann R; Steinbach J; Pietzsch J
Amino Acids; 2011 Oct; 41(4):809-20. PubMed ID: 21153848
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction mechanisms involved in S100A4-induced activation of the transcription factor NF-kappaB.
Grotterød I; Maelandsmo GM; Boye K
BMC Cancer; 2010 May; 10():241. PubMed ID: 20507646
[TBL] [Abstract][Full Text] [Related]
15. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.
Yammani RR; Carlson CS; Bresnick AR; Loeser RF
Arthritis Rheum; 2006 Sep; 54(9):2901-11. PubMed ID: 16948116
[TBL] [Abstract][Full Text] [Related]
16. Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells.
Somensi N; Brum PO; de Miranda Ramos V; Gasparotto J; Zanotto-Filho A; Rostirolla DC; da Silva Morrone M; Moreira JCF; Pens Gelain D
Cell Physiol Biochem; 2017; 42(6):2507-2522. PubMed ID: 28848092
[TBL] [Abstract][Full Text] [Related]
17. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.
Chuong C; Katz J; Pauley KM; Bulosan M; Cha S
J Cell Physiol; 2009 Nov; 221(2):430-4. PubMed ID: 19591173
[TBL] [Abstract][Full Text] [Related]
18. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid-RAGE axis promotes lung and mammary oncogenesis via protein kinase B and regulating tumor microenvironment.
Ray R; Jangde N; Singh SK; Sinha S; Rai V
Cell Commun Signal; 2020 Oct; 18(1):170. PubMed ID: 33109194
[TBL] [Abstract][Full Text] [Related]
20. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
